Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Premkumar Christadoss

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Advances in Experimental Medicine and Biology|November 26, 2008
Targeting classical complement pathway to treat complement mediated autoimmune diseasesErdem Tüzün, Jing Li, Shamsher S Saini, et al.
Journal of Neuroimmunology|April 14, 2015
IgG1 deficiency exacerbates experimental autoimmune myasthenia gravis in BALB/c miceRuksana Huda, Richard T Strait, Erdem Tüzün, et al.
Journal of Neuroimmunology|March 11, 2006
Genetic evidence for the involvement of Fcgamma receptor III in experimental autoimmune myasthenia gravis pathogenesisErdem Tüzün, Shamsher S Saini, Huan Yang, et al.
Journal of Neuroimmunology|May 26, 2012
CD4 costimulation is not required in a novel LPS-enhanced model of myasthenia gravisWindy Allman, Huibin Qi, Shamsher S Saini, et al.
Journal of Neuroimmunology|July 22, 2004
ICOS is essential for the development of experimental autoimmune myasthenia gravisBenjamin G Scott, Huan Yang, Erdem Tüzün, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2005
Cathepsin S is required for murine autoimmune myasthenia gravis pathogenesisHuan Yang, Mrinalini Kala, Benjamin G Scott, et al.
Neuromuscular Disorders : NMD|January 24, 2006
Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravisErdem Tüzün, Shamsher S Saini, Sidharth Ghosh, et al.
Journal of Neuroimmunology|December 26, 2012
The increased expression of CD21 on AchR specified B cells in patients with myasthenia gravisWeifan Yin, Windy Allman, Song Ouyang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2005
IL-1 receptor antagonist-mediated therapeutic effect in murine myasthenia gravis is associated with suppressed serum proinflammatory cytokines, C3, and anti-acetylcholine receptor IgG1Huan Yang, Erdem Tüzün, Dhivyaa Alagappan, et al.
Molecular Immunology|November 29, 2008
Dendritic cells transduced with lentiviral-mediated RelB-specific ShRNAs inhibit the development of experimental autoimmune myasthenia gravisYong Zhang, Huan Yang, Bo Xiao, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Advances in Experimental Medicine and Biology|November 26, 2008
Targeting classical complement pathway to treat complement mediated autoimmune diseasesErdem Tüzün, Jing Li, Shamsher S Saini, et al.
Journal of Neuroimmunology|April 14, 2015
IgG1 deficiency exacerbates experimental autoimmune myasthenia gravis in BALB/c miceRuksana Huda, Richard T Strait, Erdem Tüzün, et al.
Journal of Neuroimmunology|March 11, 2006
Genetic evidence for the involvement of Fcgamma receptor III in experimental autoimmune myasthenia gravis pathogenesisErdem Tüzün, Shamsher S Saini, Huan Yang, et al.
Journal of Neuroimmunology|May 26, 2012
CD4 costimulation is not required in a novel LPS-enhanced model of myasthenia gravisWindy Allman, Huibin Qi, Shamsher S Saini, et al.
Journal of Neuroimmunology|July 22, 2004
ICOS is essential for the development of experimental autoimmune myasthenia gravisBenjamin G Scott, Huan Yang, Erdem Tüzün, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2005
Cathepsin S is required for murine autoimmune myasthenia gravis pathogenesisHuan Yang, Mrinalini Kala, Benjamin G Scott, et al.
Neuromuscular Disorders : NMD|January 24, 2006
Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravisErdem Tüzün, Shamsher S Saini, Sidharth Ghosh, et al.
Journal of Neuroimmunology|December 26, 2012
The increased expression of CD21 on AchR specified B cells in patients with myasthenia gravisWeifan Yin, Windy Allman, Song Ouyang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2005
IL-1 receptor antagonist-mediated therapeutic effect in murine myasthenia gravis is associated with suppressed serum proinflammatory cytokines, C3, and anti-acetylcholine receptor IgG1Huan Yang, Erdem Tüzün, Dhivyaa Alagappan, et al.
Molecular Immunology|November 29, 2008
Dendritic cells transduced with lentiviral-mediated RelB-specific ShRNAs inhibit the development of experimental autoimmune myasthenia gravisYong Zhang, Huan Yang, Bo Xiao, et al.
Pageof 6